Val Goodfellow
CEO @ Califia Bio Inc.
United States
Encinitas
Pharmaceuticals
-
Experience
CEO
Califia Bio Inc.
Califia Bio Inc. is developing treatments for Glaucoma and Parkinson's Disease. Our research involves inhibitors of dual leucine zipper kinase (DLK) and other kinases identified as key regulators of neuroinflammation in Glaucoma patients. We are pioneering research in the field of Pseudokinases and are exploring the development of compounds that interact with Trib3 in autophagy associated with Parkinson's Disease. http://www.califiabio.com/
Director Medicinal Chemistry
Galapagos
Director Medicinal Chemistry
Neurocrine Biosciences
Director and chemistry project leader for TRPV1, MCH, MC4 and CB1 programs Director Analytical and Compound Control Group
Team Leader
Systems Integration Drug Discovery Co
Head New Leads Discovery
Cortech
Reserarch Investigator II
Bristol Myers Squibb
Education
University of Michigan
Organic Chemistry
Val Goodfellow's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.